White label ELPA - ClinicalTrials.eu

Study on Octreotide for Nutritional Recovery After Surgery in Esophageal or Gastric Cancer Patients

Not recruiting

2 1 1 1
Investigated diseases:
- Gastric cancer
- Oesophageal carcinoma
Investigated drugs:
- Octreotide
Study on the Effect of Famotidine in Reducing P-selectin Levels in Children with Sickle Cell Disease

Not recruiting

3 1 1 1
Investigated drugs:
- Famotidine
Study on Tecovirimat for Treating Monkeypox in Patients with Confirmed Infection

Not recruiting

3 1 1
Investigated diseases:
- Monkeypox
Investigated drugs:
- Tecovirimat
+2
Study on Ganciclovir and Valganciclovir for Preventing Cytomegalovirus in High-Risk Heart Surgery Patients

Not recruiting

3 1 1
Investigated diseases:
- Cytomegalovirus infection
Investigated drugs:
- Ganciclovir
- Valganciclovir
Study on Colchicine for Reducing Inflammation in Patients with Type 1 Diabetes

Not recruiting

2 1 1
Investigated diseases:
- Type 1 diabetes mellitus
Investigated drugs:
- Colchicine
Study on Long-Term Safety of Gene Therapy for Pyruvate Kinase Deficiency Using Autologous CD34+ Cells in Adults and Children

Not recruiting

1 1 1
Investigated diseases:
- Pyruvate kinase deficiency anaemia
Investigated drugs:
- Autologous Cd34+ Hematopoietic Stem Cells Transduced Ex Vivo With A Lentiviral Vector Encoding The Codon-Optimized Version Of Pklr Gene
Study on the Effectiveness of Povidone-Iodine for Nasal Decolonization in Patients with MRSA

Not recruiting

2 1 1 1
Investigated drugs:
- Povidone, Iodinated
Study on the Effectiveness and Safety of MC2-25 Cream for Itching in Chronic Kidney Disease Patients

Not recruiting

2 1
Investigated diseases:
- Chronic kidney disease-associated pruritus
Investigated drugs:
- Alanyl Glutamine
Study of BGB-11417 for Patients with Relapsed or Refractory Mantle Cell Lymphoma

Not recruiting

1 1 1 1
Investigated diseases:
- Mantle cell lymphoma refractory
Investigated drugs:
- N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
Study of Pembrolizumab as Additional Treatment for Patients with High-Risk Locally Advanced Cutaneous Squamous Cell Carcinoma After Surgery and Radiation

Not recruiting

3 1 1
Investigated diseases:
- Squamous cell carcinoma
Investigated drugs:
- Pembrolizumab
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies